Kaitlyn Bader, Senior Editor

The Sun Pharma survey included 1003 respondents with mild to moderate acne.

Click here to answer this week's skin cancer poll.

Learn more about the in-depth topics covered in the October 2023 print issue of Dermatology Times.

Review the full list of eczema resources for your patients shared during National Eczema Awareness Month.

Prepare your patients with helpful resources during National Eczema Awareness Month.

If you weren’t able to attend the 2023 Fall Clinical Dermatology Conference or want to review our latest coverage and interviews, our full recap has you covered.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference.

Susan Taylor, MD, walked Fall Clinical attendees through an in-depth hyperpigmentation session that included melasma and its mimickers.

Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.

Primary and secondary melanoma prevention factors are necessary to reduce patients’ melanoma risk.

Catch up on coverage from the third day of the 2023 Fall Clinical Dermatology Conference.

Christopher Bunick, MD, PhD, reviews Cabtreo’s recent FDA approval and what the new triple-combination gel means for acne patients.

The goal of Arron et al’s study was to determine if the 40-GEP test could identify high-risk cSCC patients who would benefit from ART in controlling metastatic disease progression.

Shah is presenting alongside a panel of leading experts at Fall Clinical 2023.

Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference.

Francesca Tenconi, president and CEO of Children’s Skin Disease Foundation and Camp Wonder, presented at Fall Clinical 2023 about the challenges of chronic skin conditions in children.

If you weren’t able to attend the 2023 Inflammatory Disease Summit or want to review our latest coverage and interviews, our full recap has you covered.

Kristine Kucera, PA-C, gave an in-depth overview of the JAK-STAT pathway at the 2023 Inflammatory Disease Summit.

Lisa Sanglay, FNP, and Lauren Miller, PA-C, interviewed a patient at IDS 2023 who used to have debilitating atopic dermatitis before seeing Sanglay for help and who prescribed upadacitinib.

Hasbargen presented clinical cases alongside James Del Rosso, DO, at IDS 2023.

Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.

Catch up on coverage from the first day of the 2023 Fall Clinical Dermatology Conference and the Inflammatory Disease Summit.

Andrea Nguyen, PA-C, reviewed types of clinical trials, phases, expenses, and more at the 2023 Inflammatory Disease Summit.

Bhatia also shared insights into ritlecitinib for alopecia areata at Fall Clinical 2023.

Lauren Miller, PA-C, kicked off the inaugural 2023 Inflammatory Disease Summit by discussing the psychosocial impacts related to AD, PsO, and HS.

Farberg is looking forward to another year of top-notch presentations at Fall Clinical 2023.

The inaugural IDS meeting geared towards physician assistants and nurse practitioners begins the first day of Fall Clinical in Las Vegas.

Click here to answer if you're attending IDS 2023.

Half of study participants achieved treatment success vs less than one-fourth with vehicle.

Click here to answer if you're attending Fall Clinical.